Monash University researchers studying mice have found that some ageing immune cells lose their ability to fight disease, while others dampen the body’s own defences. The discovery offers a clue to why infections and cancer become a greater concern in later life.
One reason Australians aged 65 and over are offered a specially formulated flu vaccine is that the immune system can respond less strongly to vaccination in later life. Scientists have long known that our defences change as we get older. Now a study led by Monash University researchers has found that even within the same animal, immune cells can age in very different ways.
The study, published in Science Immunology, focused on CD8 T cells. These specialised white blood cells can recognise and destroy cells infected by viruses, as well as some cancer cells. By removing an infected cell, they help limit the virus’s ability to spread.
When CD8 T cells recognise certain abnormal cells, they can also destroy them before they have a chance to multiply.
“Our immune system is constantly surveying our bodies for potentially cancerous cells and eliminating them, often without us ever knowing,” says the study’s first author, Dr Daniel Thiele, of the Monash Biomedicine Discovery Institute.
Cancer becomes more common with age for several reasons. Changes to DNA that can lead to cancer accumulate over a lifetime, and the immune system’s ability to deal with abnormal cells can change as well. The Monash team set out to understand what happens to one part of that defence as it ages.
When ageing cells interfere with the immune response
Working with mice, the researchers examined what happens to the genetic instructions that govern how CD8 T cells do their jobs. Cells rely on different genes at different times. When a T cell encounters a threat, for example, it needs to activate the instructions that allow it to respond.
Ageing can change how those instructions are used.
The Monash team identified three patterns of disruption, affecting how cells adapt to unfamiliar threats, how they regulate the immune response and how they maintain their own health. That last job matters because the body needs a supply of healthy T cells ready to respond when an infection comes along. Researchers studying immunity more broadly have found that older adults tend to have fewer T cells available to recognise threats they have never encountered before.
Some T cells also remember threats the body has encountered before. That memory helps the immune system respond faster if it encounters the same threat again. Meeting a new virus calls for a different set of cells, which is why retaining a varied supply of T cells matters throughout life.
One of the most unexpected findings was a previously unidentified group of ageing T cells that actively suppressed the responses of other immune cells. That gives researchers a different problem to investigate. If some cells have become less effective at dealing with a threat, restoring their function may help. If others are holding back nearby cells, researchers may need to find a way to curb that effect.
Finding those changes in mice gives scientists a starting point for investigating whether the same kinds of cells appear in people, and whether they behave in the same way. The potential for treatment depends on those answers and on whether scientists can change the behaviour of the cells safely.
A separate clue to how our organs age
In a related study published in Immunity, the Monash team examined granzyme K, a protein made by immune cells that becomes more abundant with age. Older mice that had lived without the protein showed better heart function and less scarring, along with fewer signs of damage in the liver and kidneys. Their immune systems still showed the usual signs of ageing.
That finding raises a question with practical implications. If a protein made by immune cells contributes to damage in several organs, could blocking it later in life help protect those organs? Senior researcher Professor Nicole La Gruta says the team is investigating whether blocking granzyme K later in life could bring similar benefits. Any benefit in people would need to be tested.
What it means for older Australians
The clearest example of how we already account for immune ageing is the annual flu jab. The Australian Immunisation Handbook recommends a flu vaccination each year for people aged 65 and over. It prefers either a vaccine with an ingredient that helps produce a stronger immune response or a high-dose vaccine for this age group. The first of these is funded through the National Immunisation Program. Flu vaccination helps reduce hospital admissions from influenza and pneumonia in older people.
The longer-term question is whether researchers can help ageing immune cells do particular jobs better. For someone in their 60s or 70s, that might one day mean mounting a stronger response to a vaccine or responding better to an infection. For now, the Monash team’s contribution is to show how much can vary from one immune cell to the next, even in the same ageing body. That gives scientists a more precise place to look for ways to preserve the defences we rely on in later life.
If this type of story interests you, you might want to read our story on the true toll of Parkinson’s.
Comments 0
Join the conversation. Comments are reviewed before they appear.
Be the first to comment.
Join the conversation
Tell us who you are to post a comment. We'll remember you next time.